Targeting HER2-Positive Breast Cancer: Advances and Future Directions

By
Laurisa Dohm
-
0
74
The authors discuss the current standards of care for HER2-positive breast cancer, mechanisms of resistance to HER2-targeted therapy and new therapeutic approaches and agents, including strategies to harness the immune system.
[Nature Reviews Drug Discovery]
Abstract